CBDX

The Medical Cannabis and Wellness UCITS ETF - Acc

First Cannabis ETF in Europe*

A budding opportunity for European investors to gain targeted exposure to the medical cannabis, hemp and cannabinoids (CBD) industry.

*According to HANetf research using ETF Database 

Get in Touch Download Investor Pack
As of 08/12/2022

Fund Overview

The Medical Cannabis and Wellness UCITS ETF is Europe’s first medical cannabis ETF .*

The CBDX medical cannabis ETF seeks to provide targeted exposure to the rapidly expanding legal medical cannabis industry that is set for further growth as more countries legalise cannabis for medical use. The fund tracks a rules-based Medical Cannabis and Wellness Equity Index from Solactive, consisting of publicly listed companies conducting legal business activities across nine thematic sub-sectors in the medical cannabis, hemp and CBD industries.

Please remember that the value of your investment may go down as well as up and past performance is no indication of future performance.

*According to HANetf research using ETF Database 

Want to keep updated about CBDX and our other products?

Subscribe for updates

Why Invest in CBDX Medical Cannabis ETF?

A growing treatment for illnesses and diseases:

Medical cannabis can be used in the treatment of many of the world’s most pressing health concerns in cannabis including cancer, Alzheimer’s disease, glaucoma, epilepsy and chronic pain.  New research and increasing legalisation of cannabis use for medical purposes is creating more demand for pharmaceutical grade cannabis and related services.


Global growth of medical cannabis use:

With the full legalization of cannabis in Canada and regulatory reform in the US, more countries are adopting a legalization framework for use of medical cannabis.  As medical cannabis becomes more accepted, analysts expect the rate of cannabis reform to accelerate on a global scale.  


Targeted, legal, exposure to the medical cannabis industry:

CBDX provides targeted exposure to a new and growing industry of companies engaged in the production and associated services and products in the medical cannabis industry.  The fund has no explicit inclusion of big pharma companies in the index methodology to keep it focused on high exposure to the medical cannabis, hemp and CBD industry. Multiple levels of screening and oversight ensure companies in the index meet required laws, exchange listing rules and liquidity thresholds.

Risks

The Sub-Fund and the companies in which it invests may be subject to a higher degree of regulatory oversight and regulatory action, which may include a restriction on the types of companies that the Sub-Fund may invest in at any time

If a company becomes delisted from an exchange due to noncompliance with the rules and policies of the exchange, the Investment Manager will use reasonable endeavours to remove the company from the Sub-Fund's portfolio

The value of equities and equity-related securities can be affected by daily stock and currency market movements

Investors' capital is fully at risk and investors may not get back the amount originally invested

Exchange rate fluctuations could have a negative or positive effect on returns 6. Further risks are disclosed in the KIID and Prospectus

As of 08/12/2022

Listings & Codes

Exchange Ticker RIC SEDOL ISIN Valoren WKN CCY Listing Date
LSE CBDX LN CBDX.L BGSXSL9 IE00BG5J1M21 - - USD 22/01/2020
LSE CBDP LN CBDP.L BGSXQX7 IE00BG5J1M21 - - GBP 22/01/2020
Borsa Italiana CBDX IM CBDX.MI BK77DJ3 IE00BG5J1M21 EUR 14/01/2020
Xetra CBSX GY CBSX.DE BJBL4D5 IE00BG5J1M21 - A2PPE8 EUR 14/01/2020
SIX CBDX SW CBDX.S BMYC3S4 IE00BG5J1M21 51899559 - CHF 02/06/2020

Registrations

Fund Overview
TickerCBDX
Asset ClassEquities
Base CurrencyUSD
Income TreatmentAccumulating
Inception Date09/01/2020
IndexMedical Cannabis and Wellness Equity Index
Number of Holdings21
Rebalance FrequencyQuarterly, last business day in February, May, August and November
TER80 bps
Net Asset ValuesAs of 08/12/2022
NAV$5.09
Net Assets of Fund16,425,342.34 (USD)
Shares Outstanding3,224,000
Issuer AUM$573,808,672
Structure
Replication MethodPhysical
DomicileIreland
Financial End Year31/03
Legal FormICAV
Legal And Tax Information
UCITS EligibleYes
ISA EligibleYes
SIPP EligibleYes
UK Fund Reporting Status
Key Service Providers
CustodianThe Bank of New York Mellon SA/NV, Dublin Branch
Portfolio ManagerVident Investment Advisory LLC
Index Details
IndexMedical Cannabis and Wellness Equity Index
CurrencyUSD
Index ProviderSolactive
Bloomberg TickerMEDCAWEN
CBDX Performance 1M 3M 6M YTD 12M Since Inception
(09/01/2020)
The Medical Cannabis and Wellness UCITS ETF - Acc 3.11% -7.73% -24.43% -48.81% -45.27% -32.48%
Medical Cannabis and Wellness Equity Index 2.94% -8.09% -24.70% -48.99% -45.43% -32.49%
Source: Bloomberg. as of 30 November 2022.

Performance for the fund and the index is shown in USD. Fund performance is shown net of fees with income reinvested where applicable. Please be aware that fees have a detrimental impact on the performance of an ETP. Past performance is not an indicator for future results

Monthly Reports

Monthly ReportsNovember 2022

Medical Cannabis Monthly Report | November
Read More

Monthly ReportsOctober 2022

Medical Cannabis Monthly Report | October
Read More

Monthly ReportsAugust 2022

Medical Cannabis Monthly Report | August
Read More

Webinars

WebinarSeptember 2020

Medical Cannabis: Behind the Scenes and Introduction to the CBD Industry | 9th September 2020
Read More

WebinarSeptember 2021

Cannabis Capital Markets Forum 2021 | September 7th 2021
Read More

Press Releases

PressAugust 2022

HANetf taps into growing Spanish ETF demand, registering 19 ETFs
Read More

PressAugust 2022

Over 40% of HANetf’s UCITS ETFs have successful sister products in the US
Read More

PressMarch 2021

Europe’s first medical cannabis and carbon avoidance solutions themed ETFs to list on Vienna Stock Exchange
Read More

Videos

VideosJanuary 2022

Video | Purpose Investments: 'Fundamentals remain strong' for clean energy and enterprise software

Sign up to receive your investor pack and email alerts

Related Content

Listings & Codes

Exchange Ticker RIC SEDOL ISIN Valoren WKN CCY Listing Date
LSE CBDX LN CBDX.L BGSXSL9 IE00BG5J1M21 - - USD 22/01/2020
LSE CBDP LN CBDP.L BGSXQX7 IE00BG5J1M21 - - GBP 22/01/2020
Borsa Italiana CBDX IM CBDX.MI BK77DJ3 IE00BG5J1M21 EUR 14/01/2020
Xetra CBSX GY CBSX.DE BJBL4D5 IE00BG5J1M21 - A2PPE8 EUR 14/01/2020
SIX CBDX SW CBDX.S BMYC3S4 IE00BG5J1M21 51899559 - CHF 02/06/2020

How to Buy CBDX

HANetf funds are available to buy through self-directed platforms and brokers, and intermediary platforms across Europe listed in the link below. If you would like more information on how to trade with APs/market makers, please contact our Capital Markets Team at [email protected]

Read More

CBDX ESG Rating

CBDX has been classified as an Article 6 investment under the EU Sustainable Finance Disclosure Regulation (SFDR).

About Purpose Investments

Purpose Investments is an asset management company with over $8 billion in assets under management. Purpose Investments has an unrelenting focus on client-centric innovation, and offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif and is a division of Purpose Financial, an independent technology-driven financial services company. www.purposeinvest.com

Contact Us

Tell us how we can help